A randomised multi-centre open-label phase 3 study of the Bruton's tyrosine kinase inhibitor PCI-32765 versus chlorambucil in patients 65 years or older with treatment-naive chronic lymphocytic leukem
- Coughlin, Paul (Primary Chief Investigator (PCI))
Project: Research